Elevated, FcεRI‐dependent MRGPRX2 expression on basophils in chronic urticaria

Abstract Background Chronic urticaria (CU) is a skin condition driven by mast cells and basophils. The exact responsiveness profile of these cells, especially regarding the anti‐IgE treatment, Omalizumab, is not fully investigated. We sought to characterize the surface activation profile of basophil...

Full description

Bibliographic Details
Main Authors: Ewa A. Bartko, Jesper Elberling, Lars H. Blom, Lars K. Poulsen, Bettina M. Jensen
Format: Article
Language:English
Published: Wiley 2023-06-01
Series:Skin Health and Disease
Online Access:https://doi.org/10.1002/ski2.195
_version_ 1797814337485668352
author Ewa A. Bartko
Jesper Elberling
Lars H. Blom
Lars K. Poulsen
Bettina M. Jensen
author_facet Ewa A. Bartko
Jesper Elberling
Lars H. Blom
Lars K. Poulsen
Bettina M. Jensen
author_sort Ewa A. Bartko
collection DOAJ
description Abstract Background Chronic urticaria (CU) is a skin condition driven by mast cells and basophils. The exact responsiveness profile of these cells, especially regarding the anti‐IgE treatment, Omalizumab, is not fully investigated. We sought to characterize the surface activation profile of basophils in CU during Omalizumab treatment and their responsiveness to IgE and non‐IgE stimulation. Methods Whole blood basophils from 11 CU patients and 10 healthy controls were stimulated with either medium, anti‐IgE, fMLP, C5a, or Substance P for 30 min and characterized by flow cytometry. Results CU patients showed a broad range of basophil count as opposed to healthy subjects. An increased number of unstimulated CD69+ (p = 0.05), but not CD63+ basophils was observed in CU groups in comparison to healthy. The expression of CD203c and CD200R were comparable between all groups, whilst the FcεRI was reduced with the treatment. Both IgE and non‐IgE mediated stimulations upregulated CD63, CD203c and CD200R, but not CD69 in all groups, however, no difference between the groups was observed. Among unstimulated basophils, expression of MRGPRX2 was higher in CU patients after Omalizumab treatment than in the healthy group (2.4% vs. 1.5%, p = 0.01). The anti‐IgE stimulation increased the number of MRGPRX2‐expressing basophils in the CU group before and after omalizumab as compared to the healthy (p = 0.003; p = 0.005). The fMLP and C5a stimulations showed a similar effect to the IgE‐mediated stimulation. The MRGPRX2 ligand, Substance P did not activate basophils. Conclusion CU basophils show increased expression of MRGPRX2 after IgE and non‐IgE stimulation.
first_indexed 2024-03-13T08:06:11Z
format Article
id doaj.art-504c1c8c5cc24ab9a87952e53bc3d580
institution Directory Open Access Journal
issn 2690-442X
language English
last_indexed 2024-03-13T08:06:11Z
publishDate 2023-06-01
publisher Wiley
record_format Article
series Skin Health and Disease
spelling doaj.art-504c1c8c5cc24ab9a87952e53bc3d5802023-06-01T05:13:40ZengWileySkin Health and Disease2690-442X2023-06-0133n/an/a10.1002/ski2.195Elevated, FcεRI‐dependent MRGPRX2 expression on basophils in chronic urticariaEwa A. Bartko0Jesper Elberling1Lars H. Blom2Lars K. Poulsen3Bettina M. Jensen4Allergy Clinic Department of Dermatology and Allergy Copenhagen University Hospital at Gentofte Hellerup DenmarkAllergy Clinic Department of Dermatology and Allergy Copenhagen University Hospital at Gentofte Hellerup DenmarkAllergy Clinic Department of Dermatology and Allergy Copenhagen University Hospital at Gentofte Hellerup DenmarkAllergy Clinic Department of Dermatology and Allergy Copenhagen University Hospital at Gentofte Hellerup DenmarkAllergy Clinic Department of Dermatology and Allergy Copenhagen University Hospital at Gentofte Hellerup DenmarkAbstract Background Chronic urticaria (CU) is a skin condition driven by mast cells and basophils. The exact responsiveness profile of these cells, especially regarding the anti‐IgE treatment, Omalizumab, is not fully investigated. We sought to characterize the surface activation profile of basophils in CU during Omalizumab treatment and their responsiveness to IgE and non‐IgE stimulation. Methods Whole blood basophils from 11 CU patients and 10 healthy controls were stimulated with either medium, anti‐IgE, fMLP, C5a, or Substance P for 30 min and characterized by flow cytometry. Results CU patients showed a broad range of basophil count as opposed to healthy subjects. An increased number of unstimulated CD69+ (p = 0.05), but not CD63+ basophils was observed in CU groups in comparison to healthy. The expression of CD203c and CD200R were comparable between all groups, whilst the FcεRI was reduced with the treatment. Both IgE and non‐IgE mediated stimulations upregulated CD63, CD203c and CD200R, but not CD69 in all groups, however, no difference between the groups was observed. Among unstimulated basophils, expression of MRGPRX2 was higher in CU patients after Omalizumab treatment than in the healthy group (2.4% vs. 1.5%, p = 0.01). The anti‐IgE stimulation increased the number of MRGPRX2‐expressing basophils in the CU group before and after omalizumab as compared to the healthy (p = 0.003; p = 0.005). The fMLP and C5a stimulations showed a similar effect to the IgE‐mediated stimulation. The MRGPRX2 ligand, Substance P did not activate basophils. Conclusion CU basophils show increased expression of MRGPRX2 after IgE and non‐IgE stimulation.https://doi.org/10.1002/ski2.195
spellingShingle Ewa A. Bartko
Jesper Elberling
Lars H. Blom
Lars K. Poulsen
Bettina M. Jensen
Elevated, FcεRI‐dependent MRGPRX2 expression on basophils in chronic urticaria
Skin Health and Disease
title Elevated, FcεRI‐dependent MRGPRX2 expression on basophils in chronic urticaria
title_full Elevated, FcεRI‐dependent MRGPRX2 expression on basophils in chronic urticaria
title_fullStr Elevated, FcεRI‐dependent MRGPRX2 expression on basophils in chronic urticaria
title_full_unstemmed Elevated, FcεRI‐dependent MRGPRX2 expression on basophils in chronic urticaria
title_short Elevated, FcεRI‐dependent MRGPRX2 expression on basophils in chronic urticaria
title_sort elevated fcεri dependent mrgprx2 expression on basophils in chronic urticaria
url https://doi.org/10.1002/ski2.195
work_keys_str_mv AT ewaabartko elevatedfceridependentmrgprx2expressiononbasophilsinchronicurticaria
AT jesperelberling elevatedfceridependentmrgprx2expressiononbasophilsinchronicurticaria
AT larshblom elevatedfceridependentmrgprx2expressiononbasophilsinchronicurticaria
AT larskpoulsen elevatedfceridependentmrgprx2expressiononbasophilsinchronicurticaria
AT bettinamjensen elevatedfceridependentmrgprx2expressiononbasophilsinchronicurticaria